Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

221.07 +1.67 (+0.76%)

Streaming Delayed Price Updated: 2:26 PM EDT, Aug 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

38 39 Next >

Analyst Ratings For Illumina ↗

March 29, 2022

Illumina (NASDAQ:ILMN) has observed the following analyst ratings within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022 ↗

March 29, 2022

Upgrades

Via Benzinga

Join Illumina on World Tuberculosis Day to Raise Awareness and Keep the Fight Up to Eradicate TB

March 24, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Celebrates Shannon Whitmore: A Real Time Revolutionary and Scientific Computing Innovator

March 22, 2022

SOURCE: Illumina

Via 3BL Media

Illumina's Q4 Profit Falls Despite Topline Growth Of 26% ↗

February 11, 2022

Illumina Inc (NASDAQ: ILMN) reported

Via Benzinga

Earnings Scheduled For February 10, 2022 ↗

February 10, 2022

Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.

Via Benzinga

Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications

March 18, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe

March 16, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Launches Multiple-Gene Diagnostic Test For Cancer Patients ↗

March 15, 2022

Illumina Inc (NASDAQ: ILMN) has launched TruSight Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal the...

Via Benzinga

Illumina and Trivitron Partner to Accelerate Disease Detection and Diagnosis for Patients in India

March 15, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Named One of Fast Company's Most Innovative Companies for 2022

March 09, 2022

SOURCE: Illumina

Via 3BL Media

Celebrating Women's History Month: Illumina Spotlights Scientist Geraldine Pittman Woods

March 08, 2022

SOURCE: Illumina

Via 3BL Media

Illumina's Technology Supports Biodiversity and Conservation Initiatives

March 04, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Celebrates Rare Disease Day

March 01, 2022

SOURCE: Illumina

Via 3BL Media

CNBC's Final Trades: iShares MSCI UK, Illumina, US Silica And This Company That Has An Attractive Buyout Deal ↗

February 27, 2022

On CNBC’s “Halftime Report...

Via Benzinga

“The World Expands”: Celebrating Rare Disease Day in Japan

February 24, 2022

SOURCE: Illumina

Via 3BL Media

Bionano Stock Looks to Have a Monster Comeback in Its Future ↗

February 17, 2022

Bionano's Saphyr appears to be able to help doctors treat leukemia, and the adoption of its device is growing rapidly.

Via InvestorPlace

African Coronavirus Surveillance Network Provides Early Warning for World

February 17, 2022

SOURCE: Illumina

Via 3BL Media

Give peace a chance ↗

February 15, 2022

Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today.

Via Talk Markets

From Patents to Patients: Meet the Women Making a Difference at Illumina

February 15, 2022

SOURCE: Illumina

Via 3BL Media

Topics Intellectual Property

Illumina to Support Neuro Genomics Project at McGill University

February 14, 2022

SOURCE: Illumina

Via 3BL Media

Barron's Latest Picks And Pans: Zillow, Coca Cola, Illumina, Spotify And More ↗

February 12, 2022

This weekend's Barron's cover story says there will be a dramatic increase in betting on this year's Super Bowl, a trend that's likely to continue for years to...

Via Benzinga

Dominion Energy, Under Armour, And Expedia Among Another Slew Of Earnings Reports ↗

February 11, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. (Friday Market Open) Equity index...

Via Benzinga

Expert Ratings For Illumina ↗

February 11, 2022

Over the past 3 months, 5 analysts have published their opinion on Illumina (NASDAQ:ILMN) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO ↗

February 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

February 11, 2022

SVB Leerink cut Illumina, Inc. (NASDAQ: ILMN) price target from $430 to $400. Illumina shares fell 0.7% to $355.70 in pre-market trading.

Via Benzinga

A Peek Into The Markets: US Stock Futures Down Following Thursday's Plunge ↗

February 11, 2022

Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 500 points in the previous session. Investors are awaiting earnings...

Via Benzinga

5 Stocks To Watch For February 11, 2022 ↗

February 11, 2022

Some of the stocks that may grab investor focus today are:

Via Benzinga

Illumina: Q4 Earnings Insights ↗

February 10, 2022

Illumina (NASDAQ:ILMN) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Illumina beat estimated earnings...

Via Benzinga

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly ↗

February 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

38 39 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.